Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 26, 2013
Patent Application Number
12938633
Date Filed
November 3, 2010
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention provides compounds of formula (I), their use as an inhibitor of a p53-MDM2 interaction as well as pharmaceutical compositions comprising said compounds of formula (I)
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.